Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine. 1986

R H Meyboom, and M D Ferrari, and B P Dieleman

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002936 Cinnarizine A piperazine derivative having histamine H1-receptor and calcium-channel blocking activity with vasodilating and antiemetic properties but it induces PARKINSONIAN DISORDERS. 1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine,Cinarizina Inkey,Cinarizina Ratiopharm,Cinarizine,Cinazière,Cinna,Cinnarizin AL,Cinnarizin Siegfried,Cinnarizin Von Ct,Cinnarizin-Ratiopharm,Cinnarizine L-Tartrate,Cinnarizine L-Tartrate (1:1),Cinnarizine, (E)-Isomer,Cinnarizine, Dihydrochloride,Cinnipirine,Cisaken,Dimitronal,R-516,Stugeron,Stugeron Forte,Cinnarizin Ratiopharm,Cinnarizine L Tartrate,Dihydrochloride Cinnarizine,L-Tartrate, Cinnarizine,R 516,R516,Von Ct, Cinnarizin
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D005260 Female Females
D005444 Flunarizine Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. Flunarizin,Flunarizine Dihydrochloride,Flunarizine Hydrochloride,R-14950,Sibelium,Dihydrochloride, Flunarizine,Hydrochloride, Flunarizine,R 14950,R14950
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001480 Basal Ganglia Diseases Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA. Extrapyramidal Disorders,Basal Ganglia Disorders,Lenticulostriate Disorders,Basal Ganglia Disease,Basal Ganglia Disorder,Extrapyramidal Disorder,Lenticulostriate Disorder

Related Publications

R H Meyboom, and M D Ferrari, and B P Dieleman
June 1986, Lancet (London, England),
R H Meyboom, and M D Ferrari, and B P Dieleman
January 1993, Neurology India,
R H Meyboom, and M D Ferrari, and B P Dieleman
January 1991, Harefuah,
R H Meyboom, and M D Ferrari, and B P Dieleman
July 1997, The Journal of clinical psychiatry,
R H Meyboom, and M D Ferrari, and B P Dieleman
June 1989, Rinsho shinkeigaku = Clinical neurology,
R H Meyboom, and M D Ferrari, and B P Dieleman
April 1993, Movement disorders : official journal of the Movement Disorder Society,
R H Meyboom, and M D Ferrari, and B P Dieleman
January 1997, Movement disorders : official journal of the Movement Disorder Society,
R H Meyboom, and M D Ferrari, and B P Dieleman
September 1985, Archives of general psychiatry,
R H Meyboom, and M D Ferrari, and B P Dieleman
October 1986, Archives of general psychiatry,
R H Meyboom, and M D Ferrari, and B P Dieleman
May 2000, Journal of the neurological sciences,
Copied contents to your clipboard!